Ultrasound measurements revealed that targeting STING downregulation reduced diabetes-induced atrial enlargement, manifested by decreased atrial area and diameter (Figure 7G-H and Figure S7B), accompanied by alterations in atrial morphology (Figure 7I). This evidence concerns the gene STING1 and diabetes mellitus.